Last Price$64.9(1.2%)
Market Cap$82.3B
LTM Interest Income
$0.0
YoY Growth
N/A
3Y CAGR
N/A
5Y CAGR
N/A
Stock quality & Intrinsic value
5/10
220.8% undervalued
CVS Health Corporation Interest Income
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | $0.0 | $0.0 | $0.0 | $21.0M | $5,000.0K | $3,000.0K | $4,000.0K | $4,000.0K | $8,000.0K | $15.0M | $21.0M | $20.0M | $21.0M | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Overvalued or undervalued?
Check the intrinsic value for CVS
and see if it's the right time to invest.
CVS Health Corporation (CVS) Interest Income comparison analysis
General
LTM Interest Income
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
CVS Health CorporationCVS
$0.0
N/A
N/A
N/A
Median Peer Set
$0.0
(33.9%)
0.0%
0.0%
Humana Inc.HUM
$159.0M
(67.7%)
(21.3%)
(8.1%)
Bright Health Group, Inc.BHG
$27.0M
139.1%
N/A
N/A
Centene CorporationCNC
$0.0
(100.0%)
N/A
N/A
Elevance Health Inc.ELV
$0.0
N/A
N/A
N/A
Alignment Healthcare, Inc.ALHC
$0.0
(100.0%)
N/A
N/A
UnitedHealth Group IncorporatedUNH
$0.0
N/A
N/A
N/A
Cigna CorporationCI
$0.0
N/A
N/A
N/A
Clover Health Investments, Corp.CLOV
$0.0
(100.0%)
N/A
(100.0%)
Oscar Health, Inc.OSCR
$0.0
(100.0%)
N/A
N/A
Molina Healthcare, Inc.MOH
$0.0
N/A
N/A
N/A
CVS key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 37,006.7 21.0% | 43,821.4 18.4% | 76,329.5 74.2% | 87,472.0 14.6% | 98,215.0 12.3% | 95,778.0 (2.5%) | 107,080.0 11.8% | 123,120.0 15.0% | 126,761.0 3.0% | 139,367.0 9.9% | 153,290.0 10.0% | 177,546.0 15.8% | 184,786.0 4.1% | 194,579.0 5.3% | 256,776.0 32.0% | 268,706.0 4.6% | 292,111.0 8.7% | 322,467.0 10.4% | 357,776.0 10.9% | 372,809.0 4.2% |
| Cost of Goods Sold (COGS) | 27,312.1 | 32,079.2 | 60,221.8 | 69,182.0 | 77,857.0 | 75,559.0 | 86,518.0 | 100,632.0 | 102,978.0 | 114,000.0 | 126,762.0 | 148,712.0 | 156,258.0 | 163,041.0 | 211,248.0 | 219,660.0 | 239,991.0 | 267,965.0 | 303,345.0 | 321,408.0 |
% margin | 9,694.6 26.2% | 11,742.2 26.8% | 16,107.7 21.1% | 18,290.0 20.9% | 20,358.0 20.7% | 20,219.0 21.1% | 20,562.0 19.2% | 22,488.0 18.3% | 23,783.0 18.8% | 25,367.0 18.2% | 26,528.0 17.3% | 28,834.0 16.2% | 28,528.0 15.4% | 31,538.0 16.2% | 45,528.0 17.7% | 49,046.0 18.3% | 52,120.0 17.8% | 54,502.0 16.9% | 54,431.0 15.2% | 51,401.0 13.8% |
| Operating Expenses | 7,675.1 | 9,300.6 | 11,314.4 | 12,244.0 | 13,933.0 | 14,082.0 | 14,231.0 | 15,278.0 | 15,746.0 | 16,568.0 | 17,053.0 | 18,448.0 | 18,990.0 | 27,517.0 | 33,541.0 | 35,135.0 | 38,810.0 | 46,548.0 | 40,688.0 | 41,606.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 7,675.1 | 9,300.6 | 11,314.4 | 12,244.2 | 13,933.0 | 14,092.0 | 14,231.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (1,279.0) |
% margin | 2,019.5 5.5% | 2,441.6 5.6% | 4,793.3 6.3% | 6,046.0 6.9% | 6,425.0 6.5% | 6,137.0 6.4% | 6,331.0 5.9% | 7,210.0 5.9% | 8,037.0 6.3% | 8,799.0 6.3% | 9,475.0 6.2% | 10,386.0 5.8% | 9,538.0 5.2% | 4,021.0 2.1% | 11,987.0 4.7% | 13,911.0 5.2% | 13,310.0 4.6% | 7,954.0 2.5% | 13,743.0 3.8% | 8,516.0 2.3% |
| Interest Income | 0.0 | 0.0 | 0.0 | 21.0 | 5.0 | 3.0 | 4.0 | 4.0 | 8.0 | 15.0 | 21.0 | 20.0 | 21.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 530.0 | 530.0 | 539.0 | 588.0 | 561.0 | 517.0 | 615.0 | 859.0 | 1,078.0 | 1,062.0 | 2,619.0 | 3,035.0 | 2,907.0 | 2,503.0 | 2,287.0 | 2,658.0 | 2,958.0 |
| Pre-tax Income | 1,909.0 | 2,225.8 | 4,358.7 | 5,537.0 | 5,900.0 | 5,601.0 | 5,747.0 | 6,305.0 | 7,528.0 | 7,678.0 | 8,616.0 | 8,637.0 | 8,268.0 | 1,406.0 | 8,997.0 | 9,770.0 | 10,537.0 | 5,836.0 | 11,173.0 | 6,148.0 |
% effective tax rate | 684.3 35.8% | 856.9 38.5% | 1,721.7 39.5% | 2,193.0 39.6% | 2,200.0 37.3% | 2,179.0 38.9% | 2,258.0 39.3% | 2,436.0 38.6% | 2,928.0 38.9% | 3,033.0 39.5% | 3,386.0 39.3% | 3,317.0 38.4% | 1,637.0 19.8% | 2,002.0 142.4% | 2,366.0 26.3% | 2,569.0 26.3% | 2,548.0 24.2% | 1,509.0 25.9% | 2,805.0 25.1% | 1,562.0 25.4% |
% margin | 1,224.7 3.3% | 1,368.9 3.1% | 2,637.0 3.5% | 3,212.0 3.7% | 3,696.0 3.8% | 3,427.0 3.6% | 3,462.0 3.2% | 3,864.0 3.1% | 4,592.0 3.6% | 4,644.0 3.3% | 5,237.0 3.4% | 5,317.0 3.0% | 6,622.0 3.6% | (594.0) (0.3%) | 6,634.0 2.6% | 7,179.0 2.7% | 8,001.0 2.7% | 4,311.0 1.3% | 8,344.0 2.3% | 4,614.0 1.2% |
| EPS | 1.49 | 1.65 | 1.97 | 2.23 | 2.58 | 2.51 | 2.59 | 3.05 | 3.77 | 3.98 | 4.66 | 4.93 | 6.47 | (0.57) | 5.10 | 5.48 | 6.00 | 3.29 | 6.49 | 3.66 |
| Diluted EPS | 1.45 | 1.60 | 1.92 | 2.18 | 2.55 | 2.49 | 2.57 | 3.03 | 3.74 | 3.96 | 4.63 | 4.90 | 6.44 | (0.57) | 5.08 | 5.46 | 5.95 | 3.26 | 6.47 | 3.66 |
% margin | 2,608.6 7.0% | 3,174.9 7.2% | 5,887.9 7.7% | 7,341.0 8.4% | 7,819.0 8.0% | 7,609.0 7.9% | 7,903.0 7.4% | 8,619.0 7.0% | 9,915.0 7.8% | 10,224.0 7.3% | 11,567.0 7.5% | 12,190.0 6.9% | 11,809.0 6.4% | 6,743.0 3.5% | 16,403.0 6.4% | 17,118.0 6.4% | 17,526.0 6.0% | 12,347.0 3.8% | 18,197.0 5.1% | 13,703.0 3.7% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is CVS Health Corporation's Interest Income?
As of today, CVS Health Corporation's last 12-month Interest Income is $0.0, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is CVS Health Corporation's Interest Income growth rate?
Over the last year, CVS Health Corporation's Interest Income growth was N/A. The average annual Interest Income growth rates for CVS Health Corporation have been N/A over the past three years, N/A over the past five years.